Search & Analyze
Popular Searches
Dr. Lal Pathlabs Ltd.
Healthcare₹1,770.004.57%
24 Jul, 4:01 PM
CMP₹1,770.00
Mkt Cap₹28.28K Cr
P/E56.02
P/B11.58
ROE22.37%
52W High₹1,803.60
52W Low₹1,272.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
56.02
P/B Ratio
11.58
EV/EBITDA
30.96
Price/Sales
10.23
Dividend Yield (%)
1.22
EPS (TTM ₹)
30.11
Book Value (₹)
145.68
ROE (%)
22.37
ROCE (%)
29.56
ROA (%)
17.92
EBITDA Margin (%)
28.32
Net Profit Margin (%)
18.45
Debt/Equity
0.00
Current Ratio
3.48
Interest Coverage
30.35
Asset Turnover
0.97
Working Capital/Sales
2.48
Core EBITDA Growth (%)
12.01
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 20874.08 | 20168.82 | 22266.41 | 24613.95 | 27629.11 |
| Net Sales | 20874.08 | 20168.82 | 22266.41 | 24613.95 | 27629.11 |
| Total Income | 21399.54 | 20586.01 | 22958.06 | 25548.25 | 28641.77 |
| Total Expenditure | 15266.83 | 15270.48 | 16173.99 | 17657.99 | 19803.95 |
| Operating Profit | 6132.71 | 5315.53 | 6784.07 | 7890.26 | 8837.82 |
| Depreciation | 1081.07 | 1501.93 | 1435.97 | 1419.22 | 1618.03 |
| Exceptional Items | — | — | — | — | -300.94 |
| Profit Before Tax | 4749.82 | 3438.27 | 5054.51 | 6247.99 | 6690.85 |
| Tax | 1246.91 | 1027.5 | 1431.58 | 1325.47 | 1593.31 |
| Profit After Tax (PAT) | 3502.91 | 2410.77 | 3622.93 | 4922.52 | 5097.54 |
| EPS (₹) | 41.7 | 28.82 | 43.05 | 58.48 | 30.24 |
| Dividend Payout % | 120 | 120 | 240 | 240 | 205 |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 833.45 | 833.68 | 834.78 | 835.92 | 1675.55 |
| Reserves | 13599.77 | 15246.66 | 17146.55 | 20324.83 | 22745.3 |
| Shareholders Funds | 15016.08 | 16662.98 | 18492.83 | 21727.15 | 25081.39 |
| Total Debt | 3456.5 | 2366.71 | 833.34 | 0 | 0 |
| Total Liabilities | 23097.13 | 23451.38 | 24111.04 | 26301.71 | 30584.58 |
| Total Assets | 23097.13 | 23451.38 | 24111.04 | 26301.71 | 30584.58 |
| Book Value / Share | 173.1744 | 192.8838 | 215.402 | 253.1432 | 145.7483 |
| Assets | 23097.13 | 23451.38 | 24111.04 | 26301.71 | 30584.58 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 4466.94 | 4560.27 | 5353.34 | 5688.85 | 6356.08 |
| Investing Activities | -4492.47 | -2873.08 | -242.69 | -3031.63 | -4218.64 |
| Financing Activities | 1364.51 | -2831.83 | -4138.63 | -3340.29 | -2635.72 |
| Net Cash Flow | 1338.98 | -1144.64 | 972.02 | -683.07 | -498.28 |
LALPATHLAB
₹1,770.00
+4.57%